| Bioactivity | Cap-dependent endonuclease-IN-2 is a potent inhibitor of cap-dependent endonuclease (CEN). Not only can Cap-dependent endonuclease-IN-2 inhibit influenza virus well, but also has lower cytotoxicity, better in vivo agent kinetic properties and in vivo pharmacodynamic properties. Cap-dependent endonuclease-IN-2 has strong inhibitory effect on RNA polymerase activity of A virus (extracted from patent WO2019052565A1, compound 28)[1]. |
| Name | Cap-dependent endonuclease-IN-2 |
| Formula | C30H24FN3O7S |
| Molar Mass | 589.59 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Changhua Tang, et al. Influenza virus replication inhibitors and their uses. Patent WO2019052565A1. |
Cap-dependent endonuclease-IN-2
CAS: F: C30H24FN3O7S W: 589.59
Cap-dependent endonuclease-IN-2 is a potent inhibitor of cap-dependent endonuclease (CEN). Not only can Cap-dependent en
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.